Aclaris Therapeutics

Aclaris Therapeutics Inc. is a clinical-stage biopharmaceutical company developing a range of novel drug candidates to address the needs of patients with immune-inflammatory diseases lacking satisfactory treatment options. The company possesses a multi-stage portfolio of drug candidates driven by a robust R&D engine, exploring protein kinase regulation.